deltatrials
Completed NA INTERVENTIONAL 2-arm NCT05210816

Acceptance and Commitment Therapy (ACT) in Early Psychosis Patients

The Effect of Acceptance and Commitment Therapy on Psychotic Symptoms and Functioning Levels in Early Psychosis Patients

Sponsor: Saglik Bilimleri Universitesi

Updated 6 times since 2022 Last updated: Jun 6, 2024 Started: Jan 1, 2022 Primary completion: Jun 30, 2022 Completion: Sep 30, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05210816, this NA trial focuses on Acceptance and Commitment Therapy and Psychiatric Nursing and remains completed. Sponsored by Saglik Bilimleri Universitesi, it has been updated 6 times since 2022, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

~Feb 2022 – ~Mar 2022 · 28 days · monthly snapshotRecruiting~Mar 2022 – ~Feb 2024 · 23 months · monthly snapshotRecruiting~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

    Status: Unknown StatusCompleted

  4. Feb 2024 — Jul 2024 [monthly]

    Unknown Status NA

    Status: RecruitingUnknown Status

  5. Mar 2022 — Feb 2024 [monthly]

    Recruiting NA

Show 1 earlier version
  1. Feb 2022 — Mar 2022 [monthly]

    Recruiting NA

    First recorded

Jan 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Saglik Bilimleri Universitesi
Data source: Saglik Bilimleri Universitesi

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations